Top Story

Spark Therapeutics reports $2.3 million in revenue in first quarter

May 25, 2015

Spark Therapeutics, developer of SPK-RPE65, a potential gene therapy treatment for RPE65-mediated inherited retinal degenerations, reported $2.3 million in revenue in the first quarter of 2015 compared with $20,000 in the same quarter of 2014. The company recognized $1.3 million of revenue associated with a collaboration with Pfizer, according to a press release.

Net loss was reported at $10.4 million, or $0.58 per common share, in the first quarter compared with $4.4 million, or $0.86 per common share, in the same quarter in 2014.

VIDEO: Update on microinvasive glaucoma procedures Meeting News CoverageVideo

VIDEO: Update on microinvasive glaucoma procedures

May 24, 2015
MILAN — At the OSN Italy meeting, E. Randy Craven, MD, talks about microinvasive glaucoma procedures, specifically focusing on microstents and the option of using two…
VIDEO: Correlation between characteristics of the eye and toric IOL rotation Meeting News CoverageVideo

VIDEO: Correlation between characteristics of the eye and toric IOL rotation

May 24, 2015
MILAN — At the OSN Italy meeting, Kimiya Shimizu, MD, PhD, was awarded the Antonio Scarpa SOI Medal Lecture. In 1992, Shimizu developed one of the first toric IOLs. In…
VIDEO: Corneal disorders may affect outcomes of cataract surgery Meeting News CoverageVideo

VIDEO: Corneal disorders may affect outcomes of cataract surgery

May 23, 2015
MILAN — At the OSN Italy meeting, Nicoletta Fynn-Thompson, MD, talks about corneal disorders that can affect the outcomes of cataract surgery. Detection and treatment of…
VIDEO: Patient reported outcomes with wavefront guided and wavefront optimized LASIK Meeting News CoverageVideo

VIDEO: Patient reported outcomes with wavefront guided and wavefront optimized LASIK

May 23, 2015
MILAN — At the OSN Italy meeting, Edward Manche, MD, talks about patient-reported outcomes of a contralateral eye study comparing wavefront-guided and…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Trends and Trials: Prevention of Miosis, Postoperative Pain and Inflammation

Trends and Trials: Prevention of Miosis, Postoperative Pain, and Inflammation

This activity is supported by an educational grant from Omeros Corporation.

Postoperative inflammation is a natural side effect of cataract surgery. However, a clear consensus on the prevention…
More »
Meeting News Coverage Video
VIDEO: Correlation between characteristics of the eye and toric IOL rotation

VIDEO: Correlation between characteristics of the eye and toric IOL rotation

May 24, 2015
MILAN — At the OSN Italy meeting, Kimiya Shimizu, MD, PhD, was awarded the Antonio Scarpa SOI Medal Lecture. In 1992…
More »
morganatic-roan